Article
Author(s):
Toronto - A group of Canadian physicians who use Artecoll, an injectable currently awaiting FDA approval, is calling for the development of formal clinical guidelines and further research to help avoid adverse patient reactions.
Daily Derm Times: April 1, 2025
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Challenges and Future Directions in Microbiome Engineering
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Optimizing Vitiligo Care: Key Expert Takeaways
Dermatology Conferences and Meetings Calendar: April 2025